原发性胆汁性肝硬化药物治疗进展

被引：13

作者：

李萍英 ^{[1
]}

陆伦根 ^{[2
]}

机构：

[1] 青海省人民医院消化科

[2] 上海交通大学附属第一人民医院消化科

来源：

实用肝脏病杂志 | 2015年 / 04期

关键词：

原发性胆汁性肝硬化; 药物治疗; 进展;

D O I：

暂无

中图分类号：

R575.2 [肝硬变];

学科分类号：

100201 [内科学];

摘要：

治疗原发性胆汁性肝硬化(PBC)的药物主要包括加速胆汁排泄、免疫调节、抗纤维化以及对症治疗等。熊去氧胆酸是目前唯一被批准治疗PBC的药物,对大多数患者有较好的疗效,但仍有部分患者不应答。另外,贝特类、6-乙基鹅去氧胆酸、布地奈德等用于PBC的治疗也显示有很好的前景,这些研究结果为PBC的治疗提供了新选择。

引用

页码：441 / 444

页数：4

共 22 条

[1]

Old and Novel Therapies for Primary Biliary Cirrhosis[J] Albert Parés Semin Liver Dis 2014,

[2]

Obeticholic acid and budesonide for the treatment of primary biliary cirrhosis[J] Marina G Silveira;Keith D Lindor Expert Opinion on Pharmacotherapy 2014,

[3]

Randomized controlled trial assessing the effect of simvastatin in primary biliary cirrhosis[J] William J. Cash;Stephen O'Neill;Mark E. O'Donnell;David R. McCance;Ian S. Young;Jane McEneny;Neil I. McDougall;Michael E. Callender Liver Int 2013,

[4]

Natural history and management of primary biliary cirrhosis[J] Teru Kumagi;Nadya Al-Harthy Hepatic Medicine: Evidence and Research 2012,

[5]

Ursodeoxycholic acid and bile-acid mimetics as therapeutic agents for cholestatic liver diseases: An overview of their mechanisms of action[J] Raoul Poupon Clinics and Research in Hepatology and Gastroenterology 2012,

[6]

Role of RANK Ligand and Denosumab; a Targeted RANK Ligand Inhibitor; in Bone Health and Osteoporosis: A Review of Preclinical and Clinical Data[J] David W. Dempster;Cheryl L. Lambing;Paul J. Kostenuik;Andreas Grauer Clinical Therapeutics 2012,

[7]

Colchicine or Methotrexate; With Ursodiol; Are Effective After 20 Years in a Subset of Patients With Primary Biliary Cirrhosis[J] John Leung;Peter A. Bonis;Marshall M. Kaplan Clinical Gastroenterology and Hepatology 2011,

[8]

Primary biliary cirrhosis[J] Carlo Selmi;Christopher L Bowlus;M Eric Gershwin;Ross L Coppel The Lancet 2011,

[9]

Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid[J] C.Levy;J. A.Peter;D. R.Nelson;J.Keach;J.Petz;R.Cabrera;V.Clark;R. J.Firpi;G.Morelli;C.Soldevila‐Pico;K.Lindor Alimentary Pharmacology & Therapeutics 2010,

[10]

Triple therapy with ursodeoxycholic acid; budesonide and mycophenolate mofetil in patients with features of severe primary biliary cirrhosis not responding to ursodeoxycholic acid alone[J] N. Rabahi;Y. Chrétien;F. Gaouar;D. Wendum;L. Serfaty;O. Chazouillères;C. Corpechot;R. Poupon Gastroenterologie Clinique et Biologique 2010,

← 1 2 3 →